Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
140.62
+7.87 (5.93%)
Oct 19, 2026, 3:38 PM EDT - Market open
Twist Bioscience Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 431.8 | 376.57 | 312.97 | 245.11 | 203.57 | 132.33 |
Revenue Growth | 19.19% | 20.32% | 27.69% | 20.41% | 53.83% | 46.87% |
Gross Profit Gross Profit Growth | 224.39 | 191 | 133.35 | 89.73 | 84.24 | 51.71 |
Operating Income Operating Income Growth | -137.77 | -136.26 | -175.9 | -206.9 | -249.02 | -153.26 |
Net Income Net Income Growth | -136.72 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 |
Earnings Per Share EPS Growth | -2.23 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Americas Americas Growth | 257.24 | 225.58 | 193.88 | 151.26 | 122.47 | 77.91 |
Europe, Middle East and Africa (EMEA) Europe, Middle East and Africa (EMEA) Growth | 143.89 | 124.24 | 92.57 | 71.39 | 62.08 | 44.12 |
Asia Pacific (APAC) Asia Pacific (APAC) Growth | 30.67 | 26.75 | 26.52 | 22.46 | 19.01 | 10.3 |
Total Total Growth | 431.8 | 376.57 | 312.97 | 245.11 | 203.57 | 132.33 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 166.84 | 232.43 | 276.4 | 336.41 | 504.97 | 477.86 |
Total Debt Total Debt Growth | 108.59 | 90.57 | 85.03 | 94.07 | 94.91 | 62.92 |
Net Cash (Debt) Net Cash Growth | 58.25 | 141.86 | 191.37 | 242.34 | 410.06 | 414.94 |
Net Cash Growth | -63.05% | -25.87% | -21.03% | -40.90% | -1.18% | 63.35% |
Net Cash Per Share Net Cash Per Share Growth | 0.95 | 2.37 | 3.30 | 4.26 | 7.61 | 8.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -53.07 | -47.63 | -64.09 | -142.47 | -124.39 | -112.24 |
Capital Expenditures CapEx Growth | -40.05 | -28 | -5.08 | -27.78 | -101.86 | -27.06 |
Free Cash Flow Free Cash Flow Growth | -93.12 | -75.63 | -69.17 | -170.25 | -226.24 | -139.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 51.96% | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
Operating Margin | -31.91% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% |
Pretax Margin | -31.46% | -20.43% | -66.51% | -83.01% | -112.14% | -116.39% |
Profit Margin | -31.66% | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
FCF Margin | -21.57% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 19, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PS Ratio | 20.27 | 4.51 | 8.46 | 4.74 | 9.76 | 39.85 |